BioSpace News Archive

Eledon Pharmaceuticals (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (ALS), today announced that it plans to release financial results for the second quarter ended June 30, 2021 on Thursday, August 12, after the close of trading.

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company primarily focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, August 9, 2021, t

Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference

Align Technology, Inc. announced that it has entered into a new accelerated stock repurchase agreement with Goldman Sachs & Co LLC, to repurchase $75 million of Align’s common stock under Align’s $1.0 billion stock repurchase program announced on May 13, 2021.

Entera Bio Ltd. today announced its poster presentation titled “A Six-month Phase 2 Study of Oral PTH in Postmenopausal Women with Low Bone Mass

PAVmed Inc., a highly differentiated, multi-product, commercial-stage medical device company, announced that the Company will host a business update conference call on Monday, August 12, 2021, at 4:30 PM EDT.

Broward Health Medical Center, home to the Broward Health Graduate Medical Education Simulation Lab in Fort Lauderdale, Fla., has become the first United States medical institution to receive the VirtaMed LaparoS™ surgical training simulator.

Increase in geriatric population, rise in incidences of diabetes, obesity and chronic conditions, and technological advancements to deal with complex wounds drive the growth of the global advanced wound care market

Rise in prevalence of digestive disorders, increase in demand for biofuels, and high prevalence of chronic diseases drive the growth of the global enzymes market.

Increase in processing power of AI systems for enhanced AI capabilities, dearth of skilled healthcare professionals, and increase in applications of innovative screening methods would facilitate the growth of the artificial intelligence in healthcare market.